The effects of lactoferrin in a rat model of catecholamine cardiotoxicity

BioMetals

Volumn 22, Issue 2, 2009, Pages 353-361

  Mladěnka, Přemysl ^a   Semecký, Vladimír ^a   Bobrovová, Zuzana ^a   Nachtigal, Petr ^a   Vávrová, Jaroslava ^b   Holečková, Magdaléna ^b   Palicka, Vladimir ^b   Mazurová, Yvona ^b   Hrdina, Radomír ^a  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Catecholamines; Iron; Iron chelators; Isoprenaline; Lactoferrin; Reactive oxygen species

Indexed keywords

ALPHA TOCOPHEROL; CALCIUM; CATECHOLAMINE; COPPER; GLUTATHIONE; GLUTATHIONE PEROXIDASE; IRON; ISOPRENALINE; LACTOFERRIN; REACTIVE OXYGEN METABOLITE; SELENIUM; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TROPONIN T; ZINC;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CHELATION; CONTROLLED STUDY; ERYTHROCYTE; HEART PROTECTION; HEART STROKE VOLUME; HEMODYNAMIC PARAMETERS; HISTOLOGY; INOTROPISM; IRON BINDING CAPACITY; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; RAT; TREATMENT OUTCOME; VASCULAR RESISTANCE;

BOVINAE; RATTUS; RATTUS NORVEGICUS;

EID: 63149177190     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10534-008-9172-5     Document Type: Article

References (39)

1. FB Abdallah JM El Hage Chahine 2000 Transferrins: iron release from lactoferrin J Mol Biol 303 255 266 10.1006/jmbi.2000.4101
2. EN Baker HM Baker 2005 Molecular structure, binding properties and dynamics of lactoferrin Cell Mol Life Sci 62 2531 2539 10.1007/s00018-005-5368-9
3. EN Baker BF Anderson HM Baker CL Day M Haridas GE Norris SV Rumball CA Smith DH Thomas 1994 Three-dimensional structure of lactoferrin in various functional states Adv Exp Med Biol 357 1 12
4. RM Bennett T Kokocinski 1979 Lactoferrin turnover in man Clin Sci (Lond) 57 453 460
5. E Berenshtein B Vaisman C Goldberg-Langerman N Kitrossky AM Konijn M Chevion 2002 Roles of ferritin and iron in ischemic preconditioning of the heart Mol Cell Biochem 234-235 283 292 10.1023/A:1015923202082
6. R Bolli BS Patel MO Jeroudi XY Li JF Triana EK Lai PB McCay 1990 Iron-mediated radical reactions upon reperfusion contribute to myocardial "stunning" Am J Physiol 259 H1901 H1911
7. BE Britigan JS Serody MS Cohen 1994 The role of lactoferrin as an anti-inflammatory molecule Adv Exp Med Biol 357 143 156
8. JH Brock 2002 The physiology of lactoferrin Biochem Cell Biol 80 1 6 10.1139/o01-212
9. V Chagoya de Sanchez R Hernandez-Munoz F Lopez-Barrera L Yanez S Vidrio J Suarez MD Cota-Garza A Aranda-Fraustro D Cruz 1997 Sequential changes of energy metabolism and mitochondrial function in myocardial infarction induced by isoproterenol in rats: a long-term and integrative study Can J Physiol Pharmacol 75 1300 1311 10.1139/cjpp-75-12-1300
10. C Coudray S Pucheu F Boucher J Arnaud J de Leiris A Favier 1994 Effect of ischemia/reperfusion sequence on cytosolic iron status and its release in the coronary effluent in isolated rat hearts Biol Trace Elem Res 41 69 75 10.1007/BF02917218
11. KS Erga E Peen O Tenstad RK Reed 2000 Lactoferrin and anti-lactoferrin antibodies: effects of ironloading of lactoferrin on albumin extravasation in different tissues in rats Acta Physiol Scand 170 11 19 10.1046/j.1365-201x.2000. 00754.x
12. RA Fielding MA Violan L Svetkey LW Abad TJ Manfredi A Cosmas J Bean 2000 Effects of prior exercise on eccentric exercise-induced neutrophilia and enzyme release Med Sci Sports Exerc 32 359 364 10.1097/00005768-200002000-00015
13. JM Gutteridge SK Paterson AW Segal B Halliwell 1981 Inhibition of lipid peroxidation by the iron-binding protein lactoferrin Biochem J 199 259 261
14. G Hasenfuss 1998 Animal models of human cardiovascular disease, heart failure and hypertrophy Cardiovasc Res 39 60 76 10.1016/S0008-6363(98)00110-2
15. H Inoue M Sakai Y Kaida K Kaibara 2004 Blood lactoferrin release induced by running exercise in normal volunteers: antibacterial activity Clin Chim Acta 341 165 172 10.1016/j.cccn.2003.12.001
16. DS Kalinowski DR Richardson 2007 Future of toxicology-iron chelators and differing modes of action and toxicity: the changing face of iron chelation therapy Chem Res Toxicol 20 715 720 10.1021/tx700039c
17. H Karle NE Hansen J Malmquist AK Karle I Larsson 1979 Turnover of human lactoferrin in the rabbit Scand J Haematol 23 303 312
18. GJ Kontoghiorghes 2006 New chelation therapies and emerging chelating drugs for the treatment of iron overload Expert Opin Emerg Drugs 11 1 5 10.1517/14728214.11.1.1
19. I Kurose T Yamada R Wolf DN Granger 1994 P-selectin-dependent leukocyte recruitment and intestinal mucosal injury induced by lactoferrin J Leukoc Biol 55 771 777
20. Lentner C (1990) Geigy scientific tables. Ciba-Geigy, Basel
21. MH Metz-Boutigue J Jolles J Mazurier F Schoentgen D Legrand G Spik J Montreuil P Jolles 1984 Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins Eur J Biochem 145 659 676 10.1111/j.1432-1033.1984.tb08607.x
22. M Neri D Cerretani AI Fiaschi PF Laghi PE Lazzerini AB Maffione L Micheli G Bruni C Nencini G Giorgi S D'Errico C Fiore C Pomara I Riezzo E Turillazzi V Fineschi 2007 Correlation between cardiac oxidative stress and myocardial pathology due to acute and chronic norepinephrine administration in rats J Cell Mol Med 11 156 170 10.1111/j.1582-4934.2007.00009.x
23. R Oseas HH Yang RL Baehner LA Boxer 1981 Lactoferrin: a promoter of polymorphonuclear leukocyte adhesiveness Blood 57 939 945
24. ML Paffett BR Walker 2007 Vascular adaptations to hypoxia: molecular and cellular mechanisms regulating vascular tone Essays Biochem 43 105 119 10.1042/BSE0430105
25. J Parkkinen L Sahlstedt L von Bonsdorff H Salo F Ebeling T Ruutu 2006 Effect of repeated apotransferrin administrations on serum iron parameters in patients undergoing myeloablative conditioning and allogeneic stem cell transplantation Br J Haematol 135 228 234 10.1111/j.1365-2141.2006.06273.x
26. G Plomteux C Charlier A Albert M Farnier M Pressac M Vernet M Paris C Dellamonica JF Dezier 1987 Reference values of serum transferrin in newborn infants, children and adults Ann Biol Clin (Paris) 45 622 629
27. TS Raghuveer EM McGuire SM Martin BA Wagner CJ Rebouche GR Buettner JA Widness 2002 Lactoferrin in the preterm infants' diet attenuates iron-induced oxidation products Pediatr Res 52 964 972
28. BR Reddy J Wynne RA Kloner K Przyklenk 1991 Pretreatment with the iron chelator desferrioxamine fails to provide sustained protection against myocardial ischaemia-reperfusion injury Cardiovasc Res 25 711 718 10.1093/cvr/25.9.711
29. E Regoeczi PA Chindemi MT Debanne JP Prieels 1985 Lactoferrin catabolism in the rat liver Am J Physiol 248 G8 G14
30. G Rona 1985 Catecholamine cardiotoxicity J Mol Cell Cardiol 17 291 306 10.1016/S0022-2828(85)80130-9
31. A Santos-Silva I Rebelo E Castro L Belo C Catarino I Monteiro MD Almeida A Quintanilha 2002 Erythrocyte damage and leukocyte activation in ischemic stroke Clin Chim Acta 320 29 35
32. S Shimmura M Shimoyama M Hojo K Urayama K Tsubota 1998 Reoxygenation injury in a cultured corneal epithelial cell line protected by the uptake of lactoferrin Invest Ophthalmol Vis Sci 39 1346 1351
33. P Spiller MM Webb-Peploe 1985 Blood flow Eur Heart J 6 suppl C 11 18
34. M Sterba O Popelova T Simunek Y Mazurova A Potacova M Adamcova I Guncova H Kaiserova V Palicka P Ponka V Gersl 2007 Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH) Toxicology 235 150 166 10.1016/j.tox.2007.03.020
35. JL van Snick B Markowetz PL Masson 1977 The ingestion and digestion of human lactoferrin by mouse peritoneal macrophages and the transfer of its iron into ferritin J Exp Med 146 817 827 10.1084/jem.146.3.817
36. PA Ward GO Till R Kunkel C Beauchamp 1983 Evidence for role of hydroxyl radical in complement and neutrophil-dependent tissue injury J Clin Invest 72 789 801 10.1172/JCI111050
37. ED Weinberg 2003 The therapeutic potential of lactoferrin Expert Opin Investig Drugs 12 841 851 10.1517/13543784.12.5.841
38. ED Weinberg 2006 Therapeutic potential of iron chelators in diseases associated with iron mismanagement J Pharm Pharmacol 58 575 584 10.1211/jpp.58.5.0001
39. B Wolach TD Coates TE Hugli RL Baehner LA Boxer 1984 Plasma lactoferrin reflects granulocyte activation via complement in burn patients J Lab Clin Med 103 284 293